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Cholesterol is required for the growth and viability of
mammalian cells and is an obligate precursor for
steroid hormone synthesis. Using a loss-of-function
screen for mutants with defects in intracellular
cholesterol trafficking, a Chinese hamster ovary cell
mutant with haploinsufficiency of the U17 snoRNA
was isolated. U17 is an H/ACA orphan snoRNA, for
which a function other than ribosomal processing
has not previously been identified. Through expres-
sion profiling, we identified hypoxia-upregulated
mitochondrial movement regulator (HUMMR) mRNA
as a target that is negatively regulated by U17
snoRNA. Upregulation of HUMMR in U17 snoRNA-
deficient cells promoted the formation of ER-mito-
chondrial contacts, decreasing esterification of
cholesterol and facilitating cholesterol trafficking to
mitochondria. U17 snoRNA and HUMMR regulate
mitochondrial synthesis of steroids in vivo and are
developmentally regulated in steroidogenic tissues,
suggesting that the U17 snoRNA-HUMMR pathway
may serve a previously unrecognized, physiological
role in gonadal tissue maturation.
INTRODUCTION
Cholesterol is an essential cellular lipid that is a regulator of
membrane organization and fluidity, and is an obligate precursor
for synthesis of steroid hormones, oxysterols, and bile acids.
Cellular cholesterol homeostasis is tightly regulated through a
network of transcriptional and non-transcriptional pathways.
To maintain sufficient levels of cholesterol, cellular synthesis
and uptake of cholesterol is regulated by a negative feedback
loop. When cholesterol levels are low, sterol regulatory
element-binding proteins (SREBPs) upregulate genes required
for de novo cholesterol synthesis and for internalization of low-
density lipoprotein (LDL) cholesterol (Brown and Goldstein,
1999). Conversely, when cholesterol levels are elevated, the
SREBP activity is suppressed and a small portion of the excess
cholesterol is channeled to the mitochondria for synthesis of
side-chain oxysterols. These oxysterols serve as ligands for Liver
X Receptors (LXRs), nuclear hormone receptor transcriptionCfactors that promote the expression of genes responsible for
cholesterol efflux and elimination (Venkateswaran et al., 2000).
As cellular cholesterol levels decline, oxysterol synthesis is
reduced and this feedforward pathway is silenced. Crosstalk
between these transcriptional pathways provides for further
fine-tuning of these homeostatic mechanisms (Zelcer et al.,
2009).
Intracellular trafficking of cholesterol is dynamic and highly
regulated. Receptor-mediated endocytosis of lipoprotein
cholesterol and phagocytosis of apoptotic cells are accompa-
nied by increased cholesterol flux through endolysosomes and
mobilization to multiple organellar compartments, including the
plasma membrane (PM) where 60%–80% of total cellular
cholesterol resides. Expansion of the PM cholesterol pool
increases cholesterol exposure and promotes rapid internaliza-
tion of cholesterol that is independent of the endolysosomal
routes. The arrival of PM cholesterol in the ER inhibits SREBP
processing and stimulates re-esterification of cholesterol by
the ER-resident acyl CoA:cholesterol acyltransferase (ACAT).
PM cholesterol also is delivered to the mitochondria, where the
mitochondrial enzyme sterol 27-hydroxylase converts choles-
terol to 27-hydroxycholesterol (27-HC). In addition to activating
LXR, 27-HC serves as an important modulator of ER-resident
Insig proteins that are responsible for the retention of SREBP
transcription factors and that mediate rapid inactivation of
3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) (Lange
et al., 2008, 2009).
In steroidogenic tissues, trafficking of cholesterol tomitochon-
dria involves multiple routes, from endolysosomes, PM, and ER,
which ensures an ample supply of cholesterol precursor for ste-
roid hormone synthesis. Transfer of endolysosomal cholesterol
to mitochondria is thought to occur in a non-vesicular manner
between closely apposed membranes and mediated by ste-
roidogenic acute regulatory (StAR)-related lipid transfer (START)
domain proteins (Alpy and Tomasetto, 2005). MLN46, which
localizes in late endosomes, was found to facilitate cholesterol
egress from late endosome to mitochondrial membranes
(Charman et al., 2010). Similarly, StARD1, with its sterol-binding
domain and mitochondrial-targeting sequences, has been
shown to promote cholesterol uptake into the mitochondrial
outer membrane (Bose et al., 2002b). On the other hand, the
molecular basis for transfer of ER cholesterol to mitochondria,
which may occur at contact sites in mitochondria-associated
membranes, is not well understood (Rowland and Voeltz, 2012).
To further delineate intracellular cholesterol trafficking path-
ways, we initiated a loss-of-function genetic screen in Chineseell Metabolism 21, 855–867, June 2, 2015 ª2015 Elsevier Inc. 855
hamster ovary (CHO) cells, selecting for CHO mutants with
altered cholesterol trafficking (Brandis et al., 2013). In the present
study, we report the isolation and characterization of a mutant in
which the locus encoding small nucleolar RNA hosting gene 3
(Snhg3) was disrupted. Unexpectedly, we found that the choles-
terol trafficking phenotype was not due to reduced expression of
the Snhg3 mRNA, but rather resulted from haploinsufficiency of
the H/ACA small nucleolar RNA (snoRNA) U17, a small non-
coding RNA produced from the Snhg3 introns. Here we report
a previously unrecognized, non-canonical function for U17
snoRNA in the regulation of cellular cholesterol homeostasis,
and we show that changes in expression of this small non-
coding RNA are associated with postnatal maturation of ste-
roidogenic tissues in vivo.
RESULTS
Haploinsufficiency of Sngh3 Disrupts Intracellular
Cholesterol Trafficking
To identify genes involved in the regulation of cellular cholesterol
homeostasis, we performed a genetic screen in CHO cells using
an insertional mutagenesis strategy (Brandis et al., 2013). CHO
cells were mutagenized by transduction at low MOI with the
ROSAbgeo promoter trap retrovirus, which encodes a splice
acceptor, a neomycin-resistance cassette, and a poly(A) signal.
Integration of the ROSAbgeo provirus downstream of an actively
transcribed promoter and splice acceptor signal disrupts endog-
enous expression and confers resistance to neomycin (Friedrich
and Soriano, 1991). Following neomycin selection, we employed
a screen to identify cells deficient in trafficking of newly incorpo-
rated exogenous cholesterol. Mutagenized cells were choles-
terol-starved for 24 hr, followed by incubation with LDL and
treatment with amphotericin B. Amphotericin B is a polyene anti-
biotic that lyses cells through incorporation into cholesterol-rich
membranes and formation of aqueous pores, and has been used
previously to select for cholesterol trafficking mutants (Dahl
et al., 1992; Frolov et al., 2001).
One of the CHO mutants that emerged after two rounds of
LDL/amphotericin selection, mutant I5, was protected from am-
photericin B-induced cell death and resistant to Perfringolysin
O (PFO), a membrane cholesterol-binding toxin (Flanagan
et al., 2009), but was not resistant to more general inducers of
cell death, such as straurosporine and actinomycin D (Figure 1A).
LDL uptake bymutant I5 was comparable to wild-type (WT) CHO
cells (Figure 1B), indicating that the phenotype was not simply a
result of failure to internalize LDL cholesterol. The mutant also
did not accumulate endolysosomal cholesterol in response to
an LDL challenge (Figure S1A), indicating that cholesterol export
from the endolysosomal compartment was not impaired, as is
the case in Niemann-Pick C1 mutants (Millard et al., 2000).
Further characterization of the I5 mutant revealed a defect in
esterification of PM-derived cholesterol, which is comparable
to the reduced rate of PM cholesterol esterification reported
for the 3-6 cholesterol trafficking mutant isolated through a
similar LDL/amphotericin selection (Dahl et al., 1992, 1994; Ja-
cobs et al., 1997; Figure 1C). Since this cholesterol esterification
assay measures the amount of 3H-cholesterol that is trafficked
from the PM to the ER and converted to 3H-cholesteryl ester
by the ER resident enzyme ACAT, it monitors the level of the856 Cell Metabolism 21, 855–867, June 2, 2015 ª2015 Elsevier Inc.ER cholesterol pool (Jacobs et al., 1997). A trivial explanation
for the blunted cholesterol esterification might have been
reduced ACAT expression or activity. However, ACAT activity
was intact in the I5 mutant (Figure 1D). While increased hydroly-
sis of cholesteryl esters (CEs) or increased cholesterol efflux
might have contributed to the reduced rate of cholesterol ester-
ification of PM-derived cholesterol, we did not find significant
differences between mutant I5 and WT CHO cells with respect
either to cholesterol content (total, free, or ester) or to the rate
of cholesterol efflux (Figures S1B and S1C). We further found
that LDL-stimulated cholesterol esterification (Figure S1D), a
measure of lysosome to ER trafficking, and LDL-stimulated
pregnenolone production (Figure S1E), a measure of lysosome
to mitochondria cholesterol trafficking, are intact in the I5
mutant. This indicates that the esterification phenotype is spe-
cific to the pathway involved in the internalization of PM-derived
cholesterol, which is distinct from post-lysosomal distribution of
LDL-derived cholesterol. Together, these data suggest that
the cholesterol esterification phenotype resulted from either
reduced delivery of PM cholesterol to the ER or enhanced
cholesterol trafficking from ER membranes (e.g., partitioning of
cholesterol away from the ACAT-accessible cholesterol pool).
U17 snoRNA from the Snhg3 Locus Complements the
Altered Cholesterol Trafficking in I5 Cells
50 and 30 RACE were used to clone the cDNA of the gene disrup-
ted by proviral insertion in the I5 mutant. Southern blotting (Fig-
ure S1F) and PCR (Figure 1E) confirmed that a single provirus
had integrated into one of two expressed alleles for an mRNA
that lacked homology to murine and human sequences at the
cDNA level. The lack of open reading frames (ORFs) of substan-
tial length (Figure S1G) and the absence of significant homology
between the I5 cDNA sequence and other mammalian genes
(Figure S1H) suggested that the I5 locus expresses a non-coding
RNA. Using both genomic PCR and inverse PCR approaches,
the 5.4-kb genomic I5 locus was cloned. Based on conserved
promoter elements, exon/intron organization, and intronic
orphan H/ACA snoRNAsU17a and U17b, we identified this locus
as small RNA hosting gene 3 (Snhg3) (Pelczar and Filipowicz,
1998; Figure 1F). Disruption of one allele resulted in a 50%
reduction in expression of proviral-disrupted mRNA in mutant
I5, consistent with a model of haploinsufficiency (Figure 1G).
The U17 snoRNAs belong to the H/ACA snoRNA family charac-
terized by the conserved H box (ANANNA) and ACA box (Kiss
et al., 2010). In addition, U17 snoRNAs contain two evolutionarily
conserved elements m1 and m2 (Figure S1I). In the yeast U17
ortholog snR30, m1 and m2 elements base pair with pre-rRNA
sequences to mediate pre-rRNA processing for the generation
of 18S rRNA (Atzorn et al., 2004; Fayet-Lebaron et al., 2009).
However, it is not known whether this function is conserved in
higher eukaryotes.
We generated and expressed in the I5 genetic background a
series of constructs designed to determine the element within
the Sngh3 locus—mRNA or embedded snoRNAs—whose defi-
ciency is responsible for the altered cholesterol trafficking in
this mutant. GEN is a construct containing the entire genomic
locus of murine Snhg3, including 2 kb of the endogenous pro-
moter followed and 1 kb of downstream sequences; DA and
DB are GEN constructs lacking U17a and U17b, respectively;
Figure 1. Mutant I5 Is Haploinsufficient for Snhg3 and Has Altered Cholesterol Trafficking
(A) Cell death was quantified by PI staining of WT CHO (black) and mutant I5 (white) cells in standard growth media (Ctr), treated with cholesterol-binding toxins
(10mg/mlAmphotericin B [AmB] or 10mg/ml PerfringolysinO [PFO]), or treatedwith apoptosis inducers (2mMActinomycinD [ActD] or 80 nMStaurosporine [Staur]).
(B) LDL uptake in WT, I5, and LDLA7 (negative control lacking LDLR) cells was determined bymeasuring fluorescence intensity following incubation with dil-LDL.
RU, relative units.
(C) Esterification of PM-derived cholesterol at the ER membrane was measured in I5 and 3-6 mutant cells relative to WT.
(D) ACAT activity was measured in microsomes isolated from WT and I5 cells.
(E) Genomic PCR of the I5 locus was performed using combinations of primers (below) specific for the locus (forward primer for 50 exon of allele disrupted in I5,
I5(F); reverse primer for 30 exon of allele disrupted in I5, I5 (R); and ROSAbgeo reverse primer for proviral sequence, ROSA(R)).
(F) Structure of the Snhg3 locus in Cricetulus griseus, Mus musculus, and Homo sapiens. Exons are rectangles, snoRNAs are block arrows, and site of proviral
integration is indicated by an arrowhead.
(G) Steady-state levels of Snhg3 transcript in WT and I5 cells were assessed by qRT-PCR and normalized to b-actin. Data presented are mean+SE for three
independent measurements. **p < 0.01 and ***p < 0.001 for mutant versus WT.DAB is a GEN construct lacking both U17a and U17b; cDNA is a
full-length Snhg3 cDNA sequence driven by a CMV promoter;
SNO+ is a construct for expression of the U17b snoRNA from
the second intron of a modified human b-globin gene; and
MUT+ is a construct for expression of themutated U17b snoRNA
from the second intron of a modified human b-globin gene
(Figures 2A and 2B). Clonal cell lines stably expressing these
constructs were generated, analyzed for the expression of exog-
enous murine U17 snoRNA and Snhg3 mRNA by qRT-PCR
(Figures 2C and 2D), and phenotyped by esterification of
PM-derived cholesterol. Expression of the entire genomic
Snhg3 locus complemented the cholesterol trafficking pheno-
type in the I5 mutant (Figure 2E, GEN). Likewise, expression of
DA and DB constructs also complemented the I5 mutant esteri-
fication defect, suggesting that U17a and U17b are functionally
equivalent (Figures S2A and S2B). On the other hand, mRNACexpression alone failed to complement the mutant phenotype
(Figure 2E, DAB and cDNA). Consistent with these findings,
expression of only U17 snoRNA in a heterologous background
(SNO+) was sufficient to rescue the cholesterol trafficking pheno-
type. Taken together, the findings from the complementation
experiments indicated that deficiency of U17 snoRNAs, but not
the Snhg3 mRNA, was responsible for the altered cholesterol
trafficking in mutant I5.
The m1/m2 Elements Are Necessary for U17 snoRNA
Function
Based on the known functions of H/ACA snoRNAs, we hypothe-
sized that U17 forms a small nucleolar ribonucleoprotein
(snoRNP), by associating with known H/ACA core proteins,
and recognizes targets via an RNA:RNA interaction with its sin-
gle-stranded antisense element. To test whether murine U17ell Metabolism 21, 855–867, June 2, 2015 ª2015 Elsevier Inc. 857
Figure 2. U17 snoRNA of Snhg3 Locus Complements the Altered Cholesterol Trafficking in the I5 Mutant
(A) Structures of plasmid constructs for complementation are shown with exons as rectangles and snoRNAs as block arrows.
(B) Sequences that are within U17 snoRNA m1/m2 elements are shown in gray boxes. Nucleotides mutated in the MUT+ construct are shown in black.
(C and D) Clonal lines expressing the various constructs were analyzed by qRT-PCR for expression of the murine U17 snoRNA (C) and Snhg3 mRNA (D), each
normalized to b-actin. MUT+1 and MUT
+
2 are independent clonal lines expressing the MUT
+ construct, in which both m1 and m2 elements are mutated.
(E) Clones were assessed for esterification of PM-derived cholesterol. Data presented are mean + SE for four independent measurements. ***p < 0.001 for
comparisons indicated.snoRNA is present in H/ACA snoRNP complexes, epitope-
tagged H/ACA core proteins were transiently expressed, immu-
noprecipitated, and analyzed for associated snoRNAs by qPCR.
N-terminal FLAG-tagged Dyskerin or C-terminal MYC-tagged
Gar1 were enriched 10- to 20-fold with U17b, ACA28, and
E3, which are H/ACA class snoRNAs, but not with box C/D
snoRNAs such as U33 and U60 (Figure S2C; Brandis et al.,
2013; Michel et al., 2011; Wang et al., 2002; Xiao et al., 2009).
Canonical H/ACA snoRNAs use the distal loop of a pseudour-
idylation pocket to designate a target uridine for modification to
pseudouridine (Xiao et al., 2009). While target pseudouridyation
sites have not been identified for U17 snoRNA, the U17 m1/m2
boxes located in the proximal loop of 30 hairpin are highly
conserved elements that are reported to be essential in Saccha-
romyces cerevisiae for mediating 18S rRNA processing via
directly binding to pre-18S rRNA (Atzorn et al., 2004). To deter-
mine if the m1/m2 elements in U17 snoRNA are necessary for
correction of the cholesterol trafficking phenotype in the I5
mutant, 7 of 9 bases from m1 and 5 of 7 bases from m2 were
mutated in the SNO+ construct. Clonal cell lines stably express-
ing mutated U17 snoRNA from the second intron of a modified858 Cell Metabolism 21, 855–867, June 2, 2015 ª2015 Elsevier Inc.human b-globin cassette were isolated (Figures 2A and 2B,
MUT+). MUT+ clones expressing m1/m2-double-mutated U17
snoRNAat levels comparable toWTU17 snoRNA in SNO+ clones
were phenotyped with respect to esterification of PM-derived
cholesterol (Figure 2E). While mutation inm1/m2 did not interfere
with the formation of U17 snoRNP (Figures S2D and S2F), it did
abrogate the ability of U17 snoRNA to rescue the cholesterol traf-
fickingphenotype in the I5mutant. Taken together, these findings
suggest that the m1/m2 boxes are essential for U17 snoRNA
function in the regulation of cholesterol trafficking, potentially
by guiding the U17 snoRNP complex to RNA targets.
Haploinsufficiency of U17 snoRNA Does Not Affect 18S
rRNA Maturation
In Saccharomyces cerevisiae, absence of the yeast ortholog of
U17 snoRNA, snR30, led to defects in processing of pre-rRNA
and a decrease in the amount of mature 18S rRNA (Fayet-
Lebaron et al., 2009). To determine if haploinsufficiency of U17
snoRNA affects 18S rRNA processing in CHO cells, cleavage
of 47S pre-rRNA at the A0 site that is mediated by U17 snoRNA
was studied by S1 nuclease protection assay (Figure 3A).
Figure 3. Haploinsufficiency of U17 snoRNA Does Not Affect 18S rRNA Maturation
RNA was prepared from WT and I5 cells and from cells transfected with scrambled siRNA (Ctr) or siRNA against U3 snoRNA-associated protein 18 (UTP18
siRNA), which is an 18S rRNA processing factor essential for the cleavage of the 50 external transcribed spacer (50 ETS) leader sequence.
(A) Scheme shows 47S pre-rRNA with A0 site where U17 is known to direct cleavage. Alignment of 50 biotin-labeled S1 probe to uncleaved and cleaved 50 ETS
results in the protection of probes of different lengths shown.
(B) Protected probes were resolved on denaturing PAGE gel and the resulting blot was probed with streptavidin-HRP.
(C) Graph shows intensity ratio of uncleaved to cleaved probe in (B) quantified by ImageJ.
(D) Amounts of 18S rRNA in WT CHO and mutant I5 were assessed by formaldehyde agarose gel electrophoresis and ethidium bromide (EtBr) staining.
(E) Graph shows quantification of levels of 18S rRNA in (D). Data presented are mean + SE for three independent measurements. **p < 0.01.Cleavage at this site was quantified by the relative amounts of
long uncleaved species and short cleaved species of biotin-
labeled probes after S1 nuclease digestion following hybridiza-
tion with total RNA. No differences were found in the ratio of
uncleaved to cleaved species between WT and I5 (Figures 3B
and 3C). RNA from cells with transient knockdown (KD) of U3
snoRNA-associated protein 18 (UTP18) was used as a positive
control (Ho¨lzel et al., 2010), and led to a significant accumulation
of uncleaved species and a reduction in cleaved species, as
evidence of defects in 18S rRNA production. A similar result
was obtained from an S1 nuclease protection assay comparing
rRNA processing in WT and U17 KD in NIH 3T3 fibroblasts
(Figure S3). Consistent with the results from S1 nuclease protec-
tion assay, there was no difference in the amount of mature 18S
rRNA between WT and mutant I5 when normalized to 28S rRNA,
whose maturation process is independent of that for 18S rRNA
(Figures 3D and 3E). Thus, 18S rRNA formation is unaffected
by U17 snoRNA haploinsufficiency. While it is possible that
U17 snoRNAmay mediate 18S rRNA processing in the mamma-
lian system, one intact allele is sufficient to support this function,Cand U17 snoRNA’s role in cholesterol trafficking is genetically
separable from a possible role in rRNA processing.
Regulation of Hypoxia-Upregulated Mitochondrial
Movement Regulator by U17 snoRNA
To investigate downstream U17 snoRNA targets and to confirm,
using an independent approach, that U17 snoRNA deficiency
perturbs cholesterol trafficking, we knocked down U17 snoRNA
in murine NIH 3T3 cells by stable expression of a small hairpin
RNA (shRNA) targeting Snhg3 or overexpression of U17 snoRNA
using the SNO+ construct (Figure 4A). KD of U17 snoRNA
reduced PM cholesterol esterification by 40% compared to WT
cells (Figure 4A). Curiously, more robust U17 snoRNA KD could
not be achieved in the NIH 3T3 cells, suggesting that a reduction
in U17 snoRNA expression beyond 50% may be deleterious to
cell survival (Fayet-Lebaron et al., 2009). Conversely, overex-
pression of U17 snoRNA resulted in an 1.5-fold increase in
PM cholesterol esterification relative to WT.
These experiments provided murine cell lines that were well
suited for analysis of potential downstream targets usingell Metabolism 21, 855–867, June 2, 2015 ª2015 Elsevier Inc. 859
Figure 4. Regulation of HUMMR by U17 snoRNA
(A) Esterification of PM-derived cholesterol was measured in NIH 3T3 cells (WT) and in NIH 3T3-derived cell lines with stable KD (KD1 and KD2) or overexpression
of U17 (SNO+1 and SNO
+
2) (left). Levels of U17 snoRNA were assessed by qRT-PCR (right).
(B) Diagram depicts genes identified as those upregulated in KD (green) and downregulated in SNO+ (red) relative to WT.
(C) Alignment of conserved human, hamster, and murine sequences on HUMMR mRNA that are complementary to m1/m2 elements on U17 snoRNA is shown.
(D) HUMMR mRNA abundance in WT, KD, and SNO+ was quantified by qRT-PCR.
(E) HUMMR protein levels in WT, KD, and SNO+ were measured by western blotting (top) and quantified (bottom).
(F) qRT-PCR quantification of co-precipitated U17 snoRNA (black), mutated U17 snoRNA (white), and U33 snoRNA (gray) in pulldown of MS2-tagged HUMMR
mRNA in the presence or absence of GST-tagged MS2-binding protein (MS2BP-GST).
(G) HUMMR mRNA newly synthesized during a 30-min pulse labeling with ethenyl uridine in WT CHO and mutant I5 was quantified by qRT-PCR (left). HUMMR
mRNA was then quantified during chase in media lacking label to determine half-life in WT CHO and mutant I5 (right). Data presented are mean + SE for three
independent measurements (ns, non-significant). *p < 0.05, **p < 0.01, and ***p < 0.001 for KD or SNO+ versus WT or for comparisons indicated.commercially available microarrays. We hypothesized that if U17
snoRNA regulates cholesterol homeostasis by modulating the
expression of target mRNAs, genes that are differentially
expressed by the loss of function or gain of function of U17
snoRNA would be candidate U17 targets. One possible model
is negative regulation of targets by U17 snoRNA, in which
increasing gene dosage of U17 snoRNA from KD to WT to
SNO+ would lead to decreases in target levels. Comparison
of the transcriptomes of KD and SNO+ cell lines with WT
identified 145 genes differentially upregulated in KD and 22
genes differentially downregulated in SNO+, relative to WT (Fig-
ure 4B). Of these, only three genes that were upregulated in KD
also were downregulated in SNO+. Of these, we chose to focus
on hypoxia-upregulated mitochondrial movement regulator
(HUMMR), which contained sequences complementary to the
U17 snoRNA m1/m2 motifs (Figure 4C) and whose expression
inversely correlated with U17 snoRNA expression both at the860 Cell Metabolism 21, 855–867, June 2, 2015 ª2015 Elsevier Inc.mRNA and protein levels (Figures 4D and 4E). This relationship
also was validated in the I5 mutant, which revealed a 3-fold in-
crease in HUMMR mRNA expression relative to WT CHO (Fig-
ure S4). The increased HUMMR expression normalized when
mutant I5 was rescued by stable expression of U17 snoRNA in
SNO+ cell line and when U17 snoRNA was stably re-introduced
to U17 KD cells (KD+).
To determine if U17 regulates HUMMRmRNA through a phys-
ical interaction, we transiently expressed U17 snoRNA and
HUMMR mRNA tagged with the MS2 aptamer at the 30 UTR
and used GST-tagged MS2 binding protein (MS2BP-GST) in
pull-down experiments (Yoon et al., 2012). Pull-down of HUMMR
byMS2-binding protein affinity purification resulted in significant
enrichment of U17 snoRNA compared to the box C/D snoRNA
U33, which was used as an unrelated snoRNA control (Figure 4F)
Enrichment was significantly greater with WT U17 snoRNA
compared to m1/m2-mutated U17 snoRNA, suggesting the
Figure 5. HUMMR Acts Downstream of U17 snoRNA to Regulate PM Cholesterol Esterification
(A and B) Graphs on the left show esterification of PM-derived cholesterol in clonal NIH 3T3 lines with stable overexpression (HUM) or KD (shHUM) of HUMMR.
Cell lines from empty vector (EV) and scrambled shRNA plasmid (shSCR) were controls. The levels of HUMMRprotein quantified fromwestern blotting are shown
on the right.
(C and D) Stable KD of HUMMR inmutant I5 cell line (C) or in NIH 3T3 U17 KD cell line (D). Clones were assessed by esterification phenotype relative to clones that
received shSCR (left). Levels of HUMMR mRNA are shown (right). Data presented are mean + SE for three independent measurements.
(E) Levels of 27-HC and pregnenolone in WT and U17 KD NIH 3T3 lines and in WT CHO and I5 mutant were quantified.
(F) Cholesterol from isolated mitochondria was measured in WT, U17 KD, and U17 SNO+ in NIH 3T3-derived cell lines.
(G–I) Following a pulse with 3H-cholesterol, ER CE (G) and mitochondrial cholesterol (H) were measured in WT CHO and mutant I5 cells. Correlation between ER
CE decrease andmitochondrial cholesterol increase is shown (I). SE on plots in (G) and (H) are containedwithin the symbols. *p < 0.05, **p < 0.01, and ***p < 0.001
for comparisons indicated.m1/m2 element is required for interaction between U17 snoRNA
and HUMMRmRNA. To determine how the steady-state level of
HUMMR mRNA is increased by a reduction in U17 snoRNA
expression, we measured the de novo transcription and half-
life of HUMMR mRNA in WT CHO and mutant I5 by pulse-chase
labeling with ethenyl uridine, a clickable uracil analog. Although
there were no difference in HUMMR transcription between WT
CHO and mutant I5 (Figure 4G, left), the half-life of HUMMR
mRNA in mutant I5 (t1/2 = 167 min) was 5-fold greater than in
WT CHO (t1/2 = 34 min) (Figure 4G, right), suggesting the
HUMMR mRNA was stabilized by the downregulation of U17
snoRNA.
HUMMR Acts Downstream of U17 snoRNA to Regulate
PM Cholesterol Esterification
HUMMR was identified previously as an outer mitochondrial
membrane (OMM) protein that serves as an adaptor for mito-
chondrial movement (Li et al., 2009). Based on the cholesterolCtrafficking phenotype in the I5 mutant and KD cell lines, we
hypothesized that HUMMR acts downstream of U17 snoRNA
to regulate PM-derived cholesterol esterification. To test this
hypothesis, we generated stable NIH 3T3 cell lines in which
HUMMR expression was either knocked down (shHUM) or over-
expressed (HUM). HUMclones phenocopied HUMMR upregula-
tion by U17 snoRNA KD and led to a decrease in cholesterol
esterification (Figure 5A). Conversely, shHUM clones phenocop-
ied HUMMR downregulation by U17 snoRNA overexpression by
increasing cholesterol esterification (Figure 5B). These results
indicated that HUMMR modulates delivery of cholesterol to the
ACAT-accessible pool in a pathway that is either parallel to or
downstream of U17 snoRNA-mediated cholesterol trafficking.
To differentiate between these possibilities, cell lines with double
KD of both U17 snoRNA and HUMMR were generated. KD of
HUMMR expression either in the mutant I5 (Figure 5C) or the
NIH 3T3 fibroblasts with U17 snoRNA KD (Figure 5D) resulted
in increased esterification relative to scrambled controls. Inell Metabolism 21, 855–867, June 2, 2015 ª2015 Elsevier Inc. 861
both cases, KD of upregulated HUMMRwas sufficient to restore
cholesterol esterification to that ofWT. This is consistent with the
cholesterol trafficking phenotype exhibited by KD of HUMMR
alone, and suggests that HUMMR functions downstream of
U17 snoRNA in this pathway.
HUMMR Attenuates Esterification of PM-Derived
Cholesterol by Diverting Cholesterol to Mitochondria
The blunted esterification of PM-derived cholesterol in the
setting of upregulation of HUMMR, an OMM adaptor protein,
raised the possibility that the altered cholesterol esterification
in the U17 snoRNA-deficient I5 mutant reflects diversion of
cholesterol from the ACAT-accessible pool in the ER to the mito-
chondria, rather than a defect in delivery of PM cholesterol to the
ER.We reasoned that HUMMRmight facilitate cholesterol flux to
mitochondria by promoting close apposition between ER and
mitochondrial membranes. Indeed, it is known that lipid traf-
ficking between ER and mitochondria occurs at sites where ER
membrane and the OMM are in close contact due to the forma-
tion of specialized complexes, referred to as mitochondrial-
associated ER membranes (MAMs) (Hayashi et al., 2009; Prinz,
2014; Rowland and Voeltz, 2012). We found that cell lines with
upregulated HUMMR expression—CHO I5 mutant and NIH
3T3 U17 snoRNA KD cells—exhibited increased mitochondrial
uptake of cholesterol, assessed by increased conversion of
cholesterol by mitochondria-specific enzymes to 27-HC in NIH
3T3 (Figure 5E, left) or pregnenolone in the CHO-derived I5
mutant (Figure 5E, right) (Charman et al., 2010; Kennedy et al.,
2012), consistent with the different mitochondrial enzymes
expressed in each cell type. Similarly, HUMMR overexpression
resulted in increased formation of 27-HC in the NIH 3T3 cells
(Figure S5A). Cholesterol levels in isolated mitochondria also
were elevated in U17 snoRNA KD relative to WT NIH 3T3
(Figure 5F). The increased level of 27-HC suggests that synthetic
capacity for oxysterols in mitochondria is unperturbed in the
setting of MAM induction by HUMMR upregulation. Further-
more, both the U17 snoRNA KD and overexpressor cell lines
had normal MitoTracker staining (Figure S5B), providing further
evidence for actively respiring mitochondria. While Mitosox
staining was elevated 2-fold in the cells with HUMMR upregu-
lation (Figure S5C), there was no evidence that the increased
HUMMR expression causes cell death (Figure 1A).
To address whether PM-derived cholesterol that fluxes
through the ER is being diverted to mitochondria, we measured
rates of cholesterol esterification and delivery of cholesterol to
mitochondria following a pulse of 3H-cholesterol to the PM.
Cholesterol esterification was decreased and mitochondrial
cholesterol increased in the U17 snoRNA-haploinsufficient cells
(I5mutant) compared toWT cells (Figures 5G and 5H).We further
found a significant linear relationship (R2 = 0.89, Figure 5I)
between the reduction in CE and the increase in mitochondrial
cholesterol. This relationship is not stoichiometric, in that the
absolute reduction in CE mass was only 1% of the increase
in mitochondrial cholesterol mass (note axes in Figure 5I), a
finding consistent with prior studies showing that only a small
fraction of the total cholesterol that transits through the ER
exceeds threshold for esterification by ACAT (Chang et al.,
1997). The total amount of cholesterol in the ER and mitochon-
dria compartments is roughly equivalent, and the rate of ester862 Cell Metabolism 21, 855–867, June 2, 2015 ª2015 Elsevier Inc.formation is used here as a proxy for the change in total ER
cholesterol, for which accurate quantification is not feasible. In
agreement with our finding that the difference in intracellular
CE is specific to the pathway involved in the internalization of
PM-derived cholesterol, LDL-stimulated production of pregnen-
olone (Figure S1E), a measure of lysosome to mitochondria traf-
ficking, also was intact in the I5 mutant.
To directly assess the effect of HUMMR expression on the
extent of ER-mitochondrial contacts, we assessed the relative
distribution of mitochondria and ER in WT, U17 snoRNA KD,
and U17 snoRNA SNO+ lines using electron microscopy (Fig-
ure 6A). Closely apposed interfaces (<40 nm) formed by ER
wrapping around mitochondria were increased in U17 snoRNA
KD compared to WT cells (Figure 6B). Moreover, the combined
length of the interfaces formed per mitochondria was increased
in U17 snoRNA KD relative to WT (Figure 6C). Although not sta-
tistically significant, a trend toward fewer and shorter interfaces
was observed in U17 snoRNA SNO+ relative to WT. Enrichment
of GRP75, a MAM protein in the crude mitochondrial fraction of
U17 snoRNA KD relative to WT NIH 3T3 (Figure 6D), suggested
that the enhanced mitochondrial contacts with the ER were
associated with the formation of MAM structures (Szabadkai
et al., 2006).
To determine whether cholesterol transfer to the mitochondria
can be similarly augmented by other mechanisms that enhance
ER-mitochondrial contacts, we measured mitochondrial choles-
terol following a cholesterol pulse in the presence and absence
of tunicamycin, an inhibitor of glycosylation and ER stress
inducer that also promotes ER-mitochondrial contacts. When
WT NIH 3T3 cells were treated with 0.5 mg/ml tunicamycin for
4 hr, a concentration at which ER-mitochondrial contacts and
ER stress are induced (Bravo et al., 2011), esterification of
PM-derived cholesterol was decreased and mitochondrial
cholesterol content was increased (Figures S5D–S5F). While it
is possible that tunicamycin-induced ER stress could have
affected ACAT activity and stimulated cholesterol transfer to
mitochondria, we found that inhibition of ACAT alone was un-
likely to explain the enhanced trafficking of cholesterol to mito-
chondria (Figure S5G). These findings indicate that induction
of ER-mitochondrial contacts, whether by HUMMR-dependent
or -independent mechanisms, is sufficient to promote chan-
neling of ER cholesterol to mitochondria.
Reciprocal Regulation of U17 snoRNA and HUMMR in
Steroidogenic Tissue
HUMMR is highly expressed in steroidogenic tissues and is regu-
lated by the hypothalamic-pituitary-gonadal axis in mice (Matsu-
moto et al., 2009; Zhou et al., 2011). Since cholesterol is an
obligate precursor for mitochondrial steroid synthesis, we exam-
ined theU17snoRNA-HUMMRpathway in steroidogenic tissues.
Tissues with higher HUMMR expression (e.g., testes, ovaries,
and adrenal glands) demonstrated relatively lower expression
of U17 snoRNA (Figure 7A). We hypothesized that if U17 snoRNA
negatively regulates HUMMR expression, then during gonadal
maturation U17 snoRNA expression would be expected to
decrease as HUMMR expression increases with age, promoting
synthesis of steroid hormone increases in gonadal tissues.
To test this reciprocal relationship, we profiled expression
of these genes in ovarian tissue of mice during postnatal
Figure 6. HUMMR Attenuates Esterification
of PM-Derived Cholesterol by Diverting
Cholesterol to Mitochondria
(A) Representative electron micrographs from WT,
U17 KD, and U17 SNO+ cells show the distribution
of ER in relation to mitochondria. Arrowheads
indicate mitochondrial membranes that are in
close proximity (<40 nm) to ER membranes. Scale
bar, 500 nm.
(B) The number of ER-OMM interfaces per micro-
meters2 is shown for WT, KD, and SNO+.
(C) The length of interface normalized by mito-
chondrial (mito) perimeter is shown for WT, KD,
and SNO+.
(D) Western blotting of crude mitochondrial and
cytosolic fractions from NIH 3T3 WT and KD cells
was probed for the MAM glucose-regulated pro-
tein 75 (GRP75), calnexin (CNX), HUMMR, and
heat shock protein 90 (HSP90). For quantification
of the mitochondrial fraction (right), GRP75 and
CNX densitometry was normalized to mitochon-
drial DNA content. Data presented are mean +SE.
*p < 0.05 and **p < 0.01.development. As HUMMR mRNA abundance increased from
postnatal day 5 to week 8, U17 snoRNA expression steadily
declined (Figure 7B). This reciprocal relationship was consistent
with a role for U17 snoRNA in gonadal tissue maturation through
regulation of HUMMR and cholesterol channeling to mitochon-
dria. To establish a causal relationship between decrease in
U17 snoRNA and increase in HUMMR mRNA and steroid hor-
mone production in vivo, we utilized antisense locked nucleic
acid (LNA) oligonucleotides to transiently knock down U17
snoRNA (Michel et al., 2011). Anti-U17 or anti-GFP (control)
LNA was injected intraperitoneally in 3-week-old mice every
other day for a week (three injections), and ovarian tissue was
harvested 2 days following the last injection. Mice injected with
anti-U17 LNA showed 30% KD of U17 snoRNA relative to
anti-GFP control (Figure 7C), which resulted in an 2-fold
increase in HUMMR mRNA and protein levels (Figures 7D and
7E). Upregulation of HUMMR led to an1.5- to 1.6-fold increase
in pregnenolone and progesterone in ovarian tissue in the U17
KD group relative to control (Figures 7F and 7G). Together, these
findings provide support for a physiological role for U17 snoRNA/
HUMMR in the regulation of steroid hormone production in
ovarian tissue in vivo.
DISCUSSION
In this study, we performed a forward genetic screen that identi-
fied a non-canonical role for the H/ACA snoRNA U17 in the
regulation of cellular cholesterol homeostasis. We establishedCell Metabolism 21, 855–that haploinsufficiency of the intron-
embedded U17 snoRNA decreased
esterification of PM-derived cholesterol
by channeling cholesterol away from the
ACAT-accessible pool in the ER and
instead to the mitochondria. Through
expression profiling, we found that the
U17 snoRNA negatively regulates theexpression of HUMMR, a mitochondrial adaptor protein that
participates in mitochondrial motility. In U17 snoRNA-deficient
cells, upregulation of HUMMR promotes ER-mitochondrial con-
tacts that facilitate oxysterol and steroid synthesis, revealing a
previously unanticipatedmechanism for regulation of cholesterol
flux to mitochondria. Our in vivo studies, showing that the
expression of U17 snoRNA and HUMMR is developmentally
regulated in postnatal steroidogenic tissues and that anti-
sense-mediated downregulation of U17 snoRNA in ovarian
tissue results in the upregulation of HUMMR and accelerated
production of steroid hormones, suggest that the U17
snoRNA-HUMMR pathway serves a physiological role in the
regulation of steroidogenesis and gonadal tissue maturation.
Recently, non-coding RNAs have emerged as potent regula-
tors of cholesterol homeostasis. Several microRNA (miRNA)
species have been characterized that specifically target choles-
terol efflux, a key step in the reverse cholesterol transport
pathway. For example, miRNA-33 has been shown to regulate
reverse cholesterol transport through the modulation of expres-
sion of ABCA1, the principal cell surface sterol transporter
responsible for cholesterol efflux and high-density lipoprotein
(HDL) biogenesis (Marquart et al., 2010; Rayner et al., 2010).
This miRNA is embeddedwithin an intron of SREBP2 and inhibits
ABCA1, a canonical LXR target, providing yet another mecha-
nism for crosstalk between the SREBP and LXR transcriptional
pathways. An LXR-suppressed miRNA, miR-26 targets choles-
terol efflux through the inhibition of expression of ABCA1 and
ADP-ribosylation factor-like 7 (ARL7) (Sun et al., 2012), and867, June 2, 2015 ª2015 Elsevier Inc. 863
Figure 7. Regulation of Steroidogenesis in Ovarian Tissue by U17 snoRNA and HUMMR
(A) HUMMR mRNA and U17 snoRNA were quantified in tissues of 8-week-old mice by qRT-PCR (normalized to Gapdh). 3b-hydroxysteroid dehydrogenase
(3bHSD) is shown as a marker of steroidogenic cells.
(B) U17 snoRNA and HUMMRmRNA expression in postnatal developing ovaries was assessed by qRT-PCR and normalized to 18S rRNA (1 week corresponds to
postnatal day 5).
(C–G) Effect of treatment with GFP LNA (control, n = 7) or U17 LNA (U17 snoRNA, n = 10) in 3-week-old mice. U17 snoRNA (C) and HUMMRmRNA (D) expression
was assessed by qPCR (normalized to Gapdh). HUMMRprotein expression (E) was determined bywestern blotting. Levels of pregnenolone (F) and progesterone
(G) in ovarian tissue were quantified by mass spectrometry-based assays.
(H) Model of U17 snoRNA-HUMMR cholesterol trafficking pathway. In the presence of U17 snoRNA (left), HUMMR expression is suppressed. Cholesterol cycling
between the PM and ER is directed to an ACAT-accessible pool and is esterified, with only a basal level of cholesterol flux to mitochondria. Deficiency of U17
snoRNA (right) alleviates suppression of HUMMR expression. Because HUMMR promotes ER-mitochondrial contacts, trafficking of PM-derived cholesterol to
mitochondria is increased. *p < 0.05, **p < 0.01, and ***p < 0.001 for comparisons indicated.activation of the farnesoid X receptor (FXR) has been shown to
upregulate miR-144, an miRNA that lowers ABCA1 expression
and HDL levels in vivo (de Aguiar Vallim et al., 2013). More
recently, we identified a requirement for the U60 box C/D
snoRNA in intracellular cholesterol trafficking, which appears
to modulate cholesterol trafficking through remodeling of mem-
brane phospholipid composition (Brandis et al., 2013).
U17 snoRNA is the first H/ACA snoRNA to be implicated in
the regulation of cholesterol homeostasis. H/ACA snoRNAs
are known to target rRNAs, tRNAs, and small nuclear RNAs
(snRNAs) for pseudouridylation through binding target se-
quences via their distal loop. However, emerging evidence sug-
gests that orphan H/ACA snoRNAs that lack complementarity to
conventional targets may serve to modify mRNAs (Karijolich and864 Cell Metabolism 21, 855–867, June 2, 2015 ª2015 Elsevier Inc.Yu, 2011; Schwartz et al., 2014). There is also evidence that
snoRNAs may be processed like miRNAs and suppress the
expression of target mRNAs (Ender et al., 2008). These findings
raise the possibility that U17 snoRNA, which also lacks comple-
mentarity to canonical pseudouridylation targets, may function
through the modulation of unconventional targets.
Indeed, we found mRNAs that are differentially regulated by
loss of function or gain of function of U17 snoRNA, one of which
was HUMMR. HUMMR does not have conserved sites that are
complementary to the distal loop of the U17 hairpin pocket,
which would be anticipated for a role in pseudouridylation,
and we have been unable to detect pseudouridylated residues
on the endogenous HUMMR mRNA (not shown). Rather, we
identified sites in HUMMR that are complementary to m1/m2
elements located in the proximal loop of the 30 hairpin of U17
snoRNA. Our observation, that exogenous expression of the
snoRNA with mutated m1/m2 elements fails to suppress
HUMMR expression and rescue the cholesterol trafficking
phenotype in mutant I5, indicates that m1/m2 are functionally
relevant motifs of U17 snoRNA. Moreover, the m1/m2 motifs
are required for physical interaction between U17snoRNA and
HUMMR mRNA. Future studies will be needed to determine
the precise domains within the HUMMR RNA required to sup-
port regulation by U17 snoRNA. Delineation of the proteome
that associates with U17 snoRNA, beyond the H/ACA snoRNA
core proteins, also may shed light on U17-directed modifica-
tions of target RNAs.
Trafficking of cholesterol to mitochondria occurs through mul-
tiple channels from endolysosomes, PM, and ER compartments.
In contrast to the transfer of cholesterol from endolysosomal
membranes to OMMs (Alpy and Tomasetto, 2005; Charman
et al., 2010), the mechanisms of cholesterol trafficking from the
ER to mitochondria are less well characterized. Contact sites
in the MAM, which are sites of lipid exchange between ER and
mitochondria, might likewise mediate cholesterol transfer
(Vance, 1990). Our findings support a model in which the coordi-
nated actions of U17 snoRNA and HUMMR regulate the forma-
tion of such ER-mitochondria contact sites (Figure 7H). Under
basal conditions, U17 snoRNA destabilizes HUMMR mRNA
and lowers HUMMR protein expression, thereby restricting
cholesterol movement to mitochondria. By contrast, in the
setting of decreased U17 snoRNA expression or U17 snoRNA
deficiency, as was the case for the CHO I5 mutant isolated in
our genetic screen, HUMMR mRNA and protein expression are
increased, facilitating MAM formation and ER to mitochondria
cholesterol flux.
Although HUMMR is induced by HIF-1 under hypoxic condi-
tions, all phenotypic assessments in our study were performed
under normoxic conditions. Thus, regulation of HUMMR expres-
sion by U17 snoRNA appears not to be restricted to hypoxic
conditions. The reduced cholesterol esterification phenotype,
therefore, is likely a consequence of diversion of the rapidly
cycling PM-derived cholesterol from an ACAT-accessible pool
to the MAM contact sites. Mitofusin 2 is an OMM protein that
has been reported to have a role in mitochondrial fusion, teth-
ering of ER to mitochondria, and most recently axonal mito-
chondria trafficking (Chen et al., 2003; de Brito and Scorrano,
2008; Misko et al., 2010). In these settings, HUMMR was shown
to interact with miro1, miro2, and Milton, adaptor proteins that
also link mitochondria to the motor protein kinesin. Whether
Mfn2 and HUMMR participate in a common tethering complex
remains to be determined. On the other hand, there is no evi-
dence that HUMMR interacts either physically or functionally
with StAR D1, another OMM protein critical for acute steroido-
genesis through its role in promoting cholesterol flux from OMM
to inner mitochondrial membrane (IMM) (Bose et al., 2002a,
2002b).
In steroidogenic cells, trafficking of cholesterol to mitochon-
dria is critical for the generation of pregnenolone, the first
committed step in steroid synthesis through the actions of the
mitochondrial cytochrome P450scc (Miller, 2011). The reciprocal
relationship between U17 snoRNA and HUMMR mRNA abun-
dance in the developing mouse ovary suggests that the U17CsnoRNA-HUMMR pathway may play a role in regulating steroid
hormone production and postnatal gonadal maturation. Enrich-
ment of HUMMR in steroidogenic tissues and its regulation
under hypothalamic-pituitary-gonadal axis is consistent with
such a role (Matsumoto et al., 2009; Zhou et al., 2011). Our find-
ings, that the developmental decline in U17 snoRNA expression
is concomitant with the de-repression of HUMMR expression
and the steroidogenic demand and that in vivo KD of U17
snoRNA increases HUMMR expression and steroid synthesis,
implicate U17 snoRNA as an upstream regulator that modulates
mitochondrial cholesterol import. Together, these findings
strongly support a physiological role for U17 snoRNA in steroid
hormone production and gonadal maturation via regulation of
HUMMR.
EXPERIMENTAL PROCEDURES
Additional details are available in the Supplemental Experimental Procedures.
Mice
C57BL/6J mice were obtained from The Jackson Laboratory. Mice were kept
in a controlled animal facility and given standard chow and water ad libitum.
Weaning occurred between 3 and 4 weeks. Experimental procedures were
approved by the Washington University Animal Studies Committees and
were conducted in accordance with the U.S. Department of Agriculture Animal
Welfare Act and the Public Health Service Policy for the Humane Care and Use
of Laboratory Animals.
Cell Culture
CHO-K1 cells and NIH 3T3 cells (American Type Culture Collection) were
cultured as previously described (Millard et al., 2000; Ory et al., 1996). For
esterification assay and measurement of RNA expression, cells were main-
tained in 5% lipoprotein-deficient media (LPDS, CoCalico Biologicals).
Generation of Amphotericin-Resistant CHO Cell Mutants
Mutant CHO-K1 clones (Friedrich and Soriano, 1991; Ory et al., 1996) were
isolated following the amphotericin B/LDL selection as described previously
(Brandis et al., 2013). The number of retroviral insertions within the mutant
cell genome was assessed by Southern blotting. Briefly, genomic DNA was
digested with restriction enzymes and separated by 0.8% agarose gel electro-
phoresis, transferred to nylon membranes, and probed with a 32P-labeled
probe (50-CTCAGGTCAAATTCAGACGG-30) corresponding to the ROSAgeo
proviral sequence.
Cell Death Assays
Cell death was assessed by membrane permeability to propidium iodide (PI)
staining as described previously (Listenberger et al., 2001). The percentage
of PI-positive cells was determined by flow cytometry or by Tecan Infinite
M200 at excitation/emission wavelengths of 535/620 nm.
Measurement of PM-Derived Cholesterol Esterification
Measurement of esterification of PM-derived cholesterol was performed as
described previously (Brandis et al., 2013). Cells were split from confluency
by one-third and grown for 24 hr. These cells were then seeded at 2.5 3 104
per well in a six-well dish for 24 hr. Media were changed to 5% LPDS for
24 hr. Cells were then pulsed for a given time with 1 mCi/ml [3H]-cholesterol
in 1 ml 5% LPDS. Cells were washed with cold Tris-buffered saline for 10 min
at 4C. Lipids were extracted from each well in 3 ml 3:2 hexane:isopropanol
and dried under nitrogen. 14C-cholesteryl oleate was added to lipid extracts
as a recovery standard. CEs were separated from cholesterol by thin-layer
chromatography (TLC) in a 130:30:2 heptane:ethyl ether:acetic acid solvent
using 100 mg and 30 mg cholesterol and CE as carriers, respectively, and
visualized by iodine. Percentage recovery of [3H]-CE was assessed by recov-
ery of [14C]-cholesteryl oleate. [3H]-cholesterol esterification was measured
as a ratio of recovery-normalized [3H]-CE to total [3H]-cholesterol.ell Metabolism 21, 855–867, June 2, 2015 ª2015 Elsevier Inc. 865
Measurement of Trafficking of PM-Derived Mitochondrial
Cholesterol to Mitochondria
Cells were plated and pulsed with [3H]-cholesterol as described for the choles-
terol esterification assay. Mitochondria were isolated using the Mitochondria
Kit for Cultured Cells (Thermo Scientific), solubilized in 0.1 N NaOH, and incor-
poration of [3H]-cholesterol into mitochondria was determined by scintillation
counting.
Microarray Sample Preparation and Data Analysis
Total RNA was isolated by TRIzol reagent (Invitrogen) from WT, U17 snoRNA
KD (ShSnhg3 stable clone), and U17 snoRNA OE (pMDbglobinU17b stable
clone) cells grown in LPDS for 24 hr, and the integrity of RNA was assessed
by BioAnalyzer 2100 (Agilent Technolgies). The cDNAwas preparedwith oligo-
deoxyribose thymidine (oligo-dT) to select for poly-A RNA. Microarray data
were generated using Illumina mouse-6 beadschip microarray at Genome
TechnologyAccessCenter (WashingtonUniversity School ofMedicine). Signif-
icance analysis of the microarray tool was used to find differentially expressed
genes betweenWT andKD (comparison 1) andWT andOE (comparison 2), at a
false discovery rate of 0%. Genes overlapping between two comparisons and
whose direction of expressional change is opposite were selected.
Measurement of Nascent mRNA and mRNA Half-Life
The amount of newly synthesized mRNA was assessed by click-it nascent
RNA capture kit (Invitrogen). Briefly, cells were incubated with 0.5mMethylene
uridine in DMEM for 30 min and harvested for total RNA. For half-life measure-
ment, cells were chased in normal growth media for indicated time points
followed by RNA harvest. EU-labeled RNAs were then chemically clicked to
biotin, pulled down by streptavidin bead, and purified. Isolated RNAs were
reverse transcribed and quantified by qRT-PCR.
Statistics
Results are expressed as mean ± SE. For group comparisons, the statistical
significance of differences in mean values was determined by a two-tailed
Student’s t test using GraphPad Prism 6 for Mac OS X (version 6.0b). A p value
of 0.05 or less was considered significant.
ACCESSION NUMBERS
The data discussed in this publication have been deposited in NCBI’s Gene
Expression Omnibus (GEO) and are accessible through GEO: GSE67569.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and one table and can be found with this article online at http://
dx.doi.org/10.1016/j.cmet.2015.04.010.
ACKNOWLEDGMENTS
This work was supported by grants to D.S.O. (HL1033001) and J.E.S.
(DK064989), and by the Washington University Diabetes Research Center
(P30 DK020579). S.J. was supported by NIH training grant T32 HL727534.
A.R. was supported by a Science Education Grant from the Howard Hughes
Medical Institute.
Received: July 24, 2014
Revised: February 19, 2015
Accepted: April 5, 2015
Published: May 14, 2015
REFERENCES
Alpy, F., and Tomasetto, C. (2005). Give lipids a START: the StAR-related lipid
transfer (START) domain in mammals. J. Cell Sci. 118, 2791–2801.
Atzorn, V., Fragapane, P., and Kiss, T. (2004). U17/snR30 is a ubiquitous
snoRNA with two conserved sequence motifs essential for 18S rRNA
production. Mol. Cell. Biol. 24, 1769–1778.866 Cell Metabolism 21, 855–867, June 2, 2015 ª2015 Elsevier Inc.Bose, H.S., Lingappa, V.R., and Miller, W.L. (2002a). Rapid regulation of
steroidogenesis by mitochondrial protein import. Nature 417, 87–91.
Bose, H.S., Lingappa, V.R., and Miller, W.L. (2002b). The steroidogenic acute
regulatory protein, StAR, works only at the outer mitochondrial membrane.
Endocr. Res. 28, 295–308.
Brandis, K.A., Gale, S., Jinn, S., Langmade, S.J., Dudley-Rucker, N., Jiang, H.,
Sidhu, R., Ren, A., Goldberg, A., Schaffer, J.E., and Ory, D.S. (2013). Box C/D
small nucleolar RNA (snoRNA) U60 regulates intracellular cholesterol
trafficking. J. Biol. Chem. 288, 35703–35713.
Bravo, R., Vicencio, J.M., Parra, V., Troncoso, R., Munoz, J.P., Bui, M.,
Quiroga, C., Rodriguez, A.E., Verdejo, H.E., Ferreira, J., et al. (2011).
Increased ER-mitochondrial coupling promotes mitochondrial respiration
and bioenergetics during early phases of ER stress. J. Cell Sci. 124, 2143–
2152.
Brown, M.S., and Goldstein, J.L. (1999). A proteolytic pathway that controls
the cholesterol content of membranes, cells, and blood. Proc. Natl. Acad.
Sci. USA 96, 11041–11048.
Chang, T.Y., Chang, C.C., and Cheng, D. (1997). Acyl-coenzyme A:cholesterol
acyltransferase. Annu. Rev. Biochem. 66, 613–638.
Charman, M., Kennedy, B.E., Osborne, N., and Karten, B. (2010). MLN64
mediates egress of cholesterol from endosomes to mitochondria in the
absence of functional Niemann-Pick Type C1 protein. J. Lipid Res. 51,
1023–1034.
Chen, H., Detmer, S.A., Ewald, A.J., Griffin, E.E., Fraser, S.E., and Chan, D.C.
(2003). Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion
and are essential for embryonic development. J. Cell Biol. 160, 189–200.
Dahl, N.K., Reed, K.L., Daunais, M.A., Faust, J.R., and Liscum, L. (1992).
Isolation and characterization of Chinese hamster ovary cells defective in the
intracellular metabolism of low density lipoprotein-derived cholesterol.
J. Biol. Chem. 267, 4889–4896.
Dahl, N.K., Daunais, M.A., and Liscum, L. (1994). A second complementation
class of cholesterol transport mutants with a variant Niemann-Pick type C
phenotype. J. Lipid Res. 35, 1839–1849.
de Aguiar Vallim, T.Q., Tarling, E.J., Kim, T., Civelek, M., Balda´n, A´., Esau, C.,
and Edwards, P.A. (2013). MicroRNA-144 regulates hepatic ATP binding
cassette transporter A1 and plasma high-density lipoprotein after activation
of the nuclear receptor farnesoid X receptor. Circ. Res. 112, 1602–1612.
de Brito, O.M., and Scorrano, L. (2008). Mitofusin 2 tethers endoplasmic retic-
ulum to mitochondria. Nature 456, 605–610.
Ender, C., Krek, A., Friedla¨nder, M.R., Beitzinger, M., Weinmann, L., Chen, W.,
Pfeffer, S., Rajewsky, N., and Meister, G. (2008). A human snoRNA with
microRNA-like functions. Mol. Cell 32, 519–528.
Fayet-Lebaron, E., Atzorn, V., Henry, Y., and Kiss, T. (2009). 18S rRNA pro-
cessing requires base pairings of snR30 H/ACA snoRNA to eukaryote-specific
18S sequences. EMBO J. 28, 1260–1270.
Flanagan, J.J., Tweten, R.K., Johnson, A.E., and Heuck, A.P. (2009).
Cholesterol exposure at the membrane surface is necessary and sufficient
to trigger perfringolysin O binding. Biochemistry 48, 3977–3987.
Friedrich, G., and Soriano, P. (1991). Promoter traps in embryonic stem cells: a
genetic screen to identify and mutate developmental genes in mice. Genes
Dev. 5, 1513–1523.
Frolov, A., Srivastava, K., Daphna-Iken, D., Traub, L.M., Schaffer, J.E., and
Ory, D.S. (2001). Cholesterol overload promotes morphogenesis of a
Niemann-Pick C (NPC)-like compartment independent of inhibition of NPC1
or HE1/NPC2 function. J. Biol. Chem. 276, 46414–46421.
Hayashi, T., Rizzuto, R., Hajnoczky, G., and Su, T.P. (2009). MAM: more than
just a housekeeper. Trends Cell Biol. 19, 81–88.
Ho¨lzel, M., Orban, M., Hochstatter, J., Rohrmoser, M., Harasim, T.,
Malamoussi, A., Kremmer, E., La¨ngst, G., and Eick, D. (2010). Defects in
18 S or 28 S rRNA processing activate the p53 pathway. J. Biol. Chem. 285,
6364–6370.
Jacobs, N.L., Andemariam, B., Underwood, K.W., Panchalingam, K.,
Sternberg, D., Kielian,M., and Liscum, L. (1997). Analysis of a Chinese hamster
ovary cell mutant with defective mobilization of cholesterol from the plasma
membrane to the endoplasmic reticulum. J. Lipid Res. 38, 1973–1987.
Karijolich, J., and Yu, Y.T. (2011). Converting nonsense codons into sense
codons by targeted pseudouridylation. Nature 474, 395–398.
Kennedy, B.E., Charman, M., and Karten, B. (2012). Niemann-Pick Type C2
protein contributes to the transport of endosomal cholesterol to mitochondria
without interacting with NPC1. J. Lipid Res. 53, 2632–2642.
Kiss, T., Fayet-Lebaron, E., and Ja´dy, B.E. (2010). Box H/ACA small ribonu-
cleoproteins. Mol. Cell 37, 597–606.
Lange, Y., Ory, D.S., Ye, J., Lanier, M.H., Hsu, F.F., and Steck, T.L. (2008).
Effectors of rapid homeostatic responses of endoplasmic reticulum choles-
terol and 3-hydroxy-3-methylglutaryl-CoA reductase. J. Biol. Chem. 283,
1445–1455.
Lange, Y., Steck, T.L., Ye, J., Lanier, M.H., Molugu, V., and Ory, D. (2009).
Regulation of fibroblast mitochondrial 27-hydroxycholesterol production by
active plasma membrane cholesterol. J. Lipid Res. 50, 1881–1888.
Li, Y., Lim, S., Hoffman, D., Aspenstrom, P., Federoff, H.J., and Rempe, D.A.
(2009). HUMMR, a hypoxia- and HIF-1alpha-inducible protein, alters mito-
chondrial distribution and transport. J. Cell Biol. 185, 1065–1081.
Listenberger, L.L., Ory, D.S., and Schaffer, J.E. (2001). Palmitate-induced
apoptosis can occur through a ceramide-independent pathway. J. Biol.
Chem. 276, 14890–14895.
Marquart, T.J., Allen, R.M., Ory, D.S., and Balda´n, A. (2010). miR-33 links
SREBP-2 induction to repression of sterol transporters. Proc. Natl. Acad.
Sci. USA 107, 12228–12232.
Matsumoto, T., Minegishi, K., Ishimoto, H., Tanaka, M., Hennebold, J.D.,
Teranishi, T., Hattori, Y., Furuya, M., Higuchi, T., Asai, S., et al. (2009).
Expression of ovary-specific acidic protein in steroidogenic tissues: a possible
role in steroidogenesis. Endocrinology 150, 3353–3359.
Michel, C.I., Holley, C.L., Scruggs, B.S., Sidhu, R., Brookheart, R.T.,
Listenberger, L.L., Behlke, M.A., Ory, D.S., and Schaffer, J.E. (2011). Small
nucleolar RNAs U32a, U33, and U35a are critical mediators of metabolic
stress. Cell Metab. 14, 33–44.
Millard, E.E., Srivastava, K., Traub, L.M., Schaffer, J.E., and Ory, D.S. (2000).
Niemann-pick type C1 (NPC1) overexpression alters cellular cholesterol
homeostasis. J. Biol. Chem. 275, 38445–38451.
Miller, W.L. (2011). Role of mitochondria in steroidogenesis. Endocr. Dev. 20,
1–19.
Misko, A., Jiang, S., Wegorzewska, I., Milbrandt, J., and Baloh, R.H. (2010).
Mitofusin 2 is necessary for transport of axonal mitochondria and interacts
with the Miro/Milton complex. J. Neurosci. 30, 4232–4240.
Ory, D.S., Neugeboren, B.A., and Mulligan, R.C. (1996). A stable human-
derived packaging cell line for production of high titer retrovirus/vesicularCstomatitis virus G pseudotypes. Proc. Natl. Acad. Sci. USA 93, 11400–
11406.
Pelczar, P., and Filipowicz, W. (1998). The host gene for intronic U17 small
nucleolar RNAs in mammals has no protein-coding potential and is a member
of the 50-terminal oligopyrimidine gene family. Mol. Cell. Biol. 18, 4509–4518.
Prinz, W.A. (2014). Bridging the gap: membrane contact sites in signaling,
metabolism, and organelle dynamics. J. Cell Biol. 205, 759–769.
Rayner, K.J., Sua´rez, Y., Da´valos, A., Parathath, S., Fitzgerald, M.L., Tamehiro,
N., Fisher, E.A., Moore, K.J., and Ferna´ndez-Hernando, C. (2010). MiR-33
contributes to the regulation of cholesterol homeostasis. Science 328, 1570–
1573.
Rowland, A.A., and Voeltz, G.K. (2012). Endoplasmic reticulum-mitochondria
contacts: function of the junction. Nat. Rev. Mol. Cell Biol. 13, 607–625.
Schwartz, S., Bernstein, D.A., Mumbach, M.R., Jovanovic, M., Herbst, R.H.,
Leo´n-Ricardo, B.X., Engreitz, J.M., Guttman, M., Satija, R., Lander, E.S.,
et al. (2014). Transcriptome-wide mapping reveals widespread dynamic-
regulated pseudouridylation of ncRNA and mRNA. Cell 159, 148–162.
Sun, D., Zhang, J., Xie, J., Wei, W., Chen, M., and Zhao, X. (2012). MiR-26
controls LXR-dependent cholesterol efflux by targeting ABCA1 and ARL7.
FEBS Lett. 586, 1472–1479.
Szabadkai, G., Bianchi, K., Va´rnai, P., De Stefani, D., Wieckowski, M.R.,
Cavagna, D., Nagy, A.I., Balla, T., and Rizzuto, R. (2006). Chaperone-mediated
coupling of endoplasmic reticulum and mitochondrial Ca2+ channels. J. Cell
Biol. 175, 901–911.
Vance, J.E. (1990). Phospholipid synthesis in a membrane fraction associated
with mitochondria. J. Biol. Chem. 265, 7248–7256.
Venkateswaran, A., Laffitte, B.A., Joseph, S.B., Mak, P.A., Wilpitz, D.C.,
Edwards, P.A., and Tontonoz, P. (2000). Control of cellular cholesterol efflux
by the nuclear oxysterol receptor LXR alpha. Proc. Natl. Acad. Sci. USA 97,
12097–12102.
Wang, C., Query, C.C., and Meier, U.T. (2002). Immunopurified small nucleolar
ribonucleoprotein particles pseudouridylate rRNA independently of their
association with phosphorylated Nopp140. Mol. Cell. Biol. 22, 8457–8466.
Xiao, M., Yang, C., Schattner, P., and Yu, Y.T. (2009). Functionality and
substrate specificity of human box H/ACA guide RNAs. RNA 15, 176–186.
Yoon, J.H., Srikantan, S., and Gorospe, M. (2012). MS2-TRAP (MS2-tagged
RNA affinity purification): tagging RNA to identify associated miRNAs.
Methods 58, 81–87.
Zelcer, N., Hong, C., Boyadjian, R., and Tontonoz, P. (2009). LXR regulates
cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor.
Science 325, 100–104.
Zhou, M., Wang, Y., Qi, S., Wang, J., and Zhang, S. (2011). The expression of a
mitochondria-localized glutamic acid-rich protein (MGARP/OSAP) is under the
regulation of the HPG axis. Endocrinology 152, 2311–2320.ell Metabolism 21, 855–867, June 2, 2015 ª2015 Elsevier Inc. 867
